“…In this context, several hypotheses have been recently proposed to explain the complexity and multifactorial pathogenesis of AD, including OS as not only a central player, but, perhaps, one of the main causative factors of NDs, unifying a series of other sequential or individual pathophysiological events ( Singh et al, 2019 ). According to this consensus, oxidative damage in the brain of patients is resultant from excessive production of free radicals induced by fragments of insoluble and/or overproduced proteins, such as β-amyloid peptide, α-synuclein, tau and huntingtin, with functional alteration in the mitochondria, inadequate energy supply, production of inflammatory mediators and alteration of antioxidant defenses ( Islam, 2016 ; Liu et al, 2017 ). Thus, the modulation of the cellular oxidative process should lead to a new concept in the design of drugs and, possibly, a new way of searching for more effective disease-modifying chemical entities, reinforcing the hope of at least real clinical relief, if healing is not yet possible ( Ghosh et al, 2011 ; Rekatsina et al, 2020 ).…”